Optimising amikacin regimens in septic patients

International Journal of Antimicrobial Agents

Volumn 39, Issue 3, 2012, Pages 264-265

  Taccone, Fabio Silvio ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CONTRAST MEDIUM; GLYCOPEPTIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

CRITICALLY ILL PATIENT; HUMAN; LETTER; LOADING DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SEPSIS;

AMIKACIN; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; PLASMA; SEPSIS;

EID: 84857061166     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.10.007     Document Type: Letter

References (5)

1. R. Gálvez, C. Luengo, R. Cornejo, J. Kosche, C. Romero, and E. Tobar Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity Int J Antimicrob Agents 38 2011 146 151
2. F.S. Taccone, P.F. Laterre, H. Spapen, T. Dugernier, I. Delattre, and B. Layeux Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock Crit Care 14 2010 R53
3. B. Layeux, F.S. Taccone, D. Fagnoul, J.L. Vincent, and F. Jacobs Amikacin monotherapy for sepsis caused by panresistant Pseudomonas aeruginosa Antimicrob Agents Chemother 54 2010 4939 4941
4. C. Bartal, A. Danon, F. Schlaeffer, K. Reisenberg, M. Alkan, and R. Smoliakov Pharmacokinetic dosing of aminoglycosides: a controlled trial Am J Med 114 2003 194 198 (Pubitemid 36294004)
5. F.S. Taccone, D. de Backer, P.F. Laterre, H. Spapen, T. Dugernier, and I. Delattre Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy Int J Antimicrob Agents 37 2011 531 535